MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 137 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $88,000 | -18.5% | 21,500 | +26.5% | 0.06% | -1.6% |
| Q3 2016 | $108,000 | +44.0% | 17,000 | +21.4% | 0.06% | +45.2% |
| Q2 2016 | $75,000 | -21.1% | 14,000 | +16.7% | 0.04% | -14.3% |
| Q4 2015 | $95,000 | -20.2% | 12,000 | -14.3% | 0.05% | -7.5% |
| Q3 2015 | $119,000 | -51.2% | 14,000 | -31.7% | 0.05% | -52.7% |
| Q1 2015 | $244,000 | -33.5% | 20,500 | -36.9% | 0.11% | -32.5% |
| Q4 2014 | $367,000 | +114.6% | 32,500 | +66.7% | 0.17% | +112.8% |
| Q3 2014 | $171,000 | +67.6% | 19,500 | +39.3% | 0.08% | +56.0% |
| Q2 2014 | $102,000 | +43.7% | 14,000 | 0.0% | 0.05% | +35.1% |
| Q1 2014 | $71,000 | -5.3% | 14,000 | 0.0% | 0.04% | -14.0% |
| Q4 2013 | $75,000 | – | 14,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 2,211,880 | $17,474,000 | 4.63% |
| Parametrica Management Ltd | 21,228 | $168,000 | 1.11% |
| GARRISON BRADFORD & ASSOCIATES INC | 82,700 | $653,000 | 0.73% |
| Virtus ETF Advisers LLC | 33,570 | $265,000 | 0.73% |
| Opus Point Partners Management, LLC | 122,500 | $968,000 | 0.64% |
| NEXTHERA CAPITAL LP | 36,000 | $284,000 | 0.40% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 7,255,815 | $57,321,000 | 0.39% |
| Cannell & Co. | 1,051,178 | $7,751,000 | 0.25% |
| Tekla Capital Management LLC | 853,787 | $6,745,000 | 0.24% |
| STONERIDGE INVESTMENT PARTNERS LLC | 208,282 | $1,645,000 | 0.22% |